GlassScriptPhysician profile
Kenneth W Plunkitt
NPI 1053304436
$12,297.27
in general payments reported to CMS, 2019-2025
12 companies · $664 in 2025
The $664 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $3,361 · 2021: $6,141 · 2022: $434 · 2023: $423 · 2024: $788 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,875.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,482.72 | 2019-2025 | Aveir, Jot Dx, Tendril |
| Cvrx, INC. | $742.50 | 2020-2025 | Barostim Neo System |
| Cardiofocus, INC. | $337.24 | 2020 | |
| Ge Healthcare | $203.43 | 2021 | |
| Impulse Dynamics (USA) INC. | $196.83 | 2021-2024 | Optimizer |
| Janssen Pharmaceuticals, INC | $143.85 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $56.90 | 2022 | |
| Novartis Pharmaceuticals Corporation | $42.02 | 2020-2022 | |
| Philips North America LLC | $34.86 | 2024 | (Cm9) Amb Mon & Diag Und |
| Baudax Bio INC. | $22.52 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.18 | 2022-2024 | Lifevest |
| Boston Scientific Corporation | $13.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Plunkitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.